Genmab Geared Up To Launch Epkinly With AbbVie

As FDA Approves CD20xCD3 Bispecific For Lymphoma

 
• By Kevin Grogan
Epkinly edges ahead of glofitamab • Source: Shutterstock

More from New Products

More from Scrip